tiprankstipranks
Trending News
More News >
Tissue Regenix (GB:TRX)
:TRX
UK Market
Advertisement

Tissue Regenix (TRX) Income Statement

Compare
14 Followers

Tissue Regenix Income Statement

Last quarter (Q2 2024), Tissue Regenix's total revenue was $12.97M, an increase of 42.02% from the same quarter last year. In Q2, Tissue Regenix's net income was $-222.17K. See Tissue Regenix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 28.65M$ 29.49M$ 19.87M$ 14.36M$ 12.83M
Gross Profit
$ 13.62M$ 14.04M$ 9.14M$ 5.63M$ 5.13M
Operating Expenses
$ 13.27M$ 14.43M$ 10.75M$ 8.61M$ 9.25M
Depreciation and Amortization
$ 1.05M$ 977.00K$ 921.43K$ 793.28K$ 762.00K
EBITDA
$ 1.36M$ 446.00K$ -690.87K$ -2.19M$ -9.03M
Operating Income
$ 349.00K$ -394.00K$ -1.61M$ -2.98M$ -4.12M
Other Income/Expenses
$ -913.00K$ -1.27M$ -285.86K$ 639.19K$ -6.12M
Pretax Income
$ -564.00K$ -1.67M$ -2.30M$ -3.74M$ -10.24M
Net Income
$ -713.00K$ -1.71M$ -2.19M$ -3.48M$ -9.71M
Per Share Metrics
Basic EPS
$ 0.00$ -0.02$ -0.03$ -0.05$ -0.22
Diluted EPS
$ 0.00$ -0.02$ -0.03$ -0.05$ -0.22
Weighted Average Shares Outstanding
0.00 70.43M 70.35M 70.33M 44.48M
Weighted Average Shares Outstanding (Diluted)
0.00 70.43M 70.35M 70.33M 44.48M
Currency in USD

Tissue Regenix Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis